Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor

References

• Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30:1663–1669. doi: 10.1200/JCO.2011.37.8018
   PubMed Web of Science ®Google Scholar
• Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373:1541–1552. doi: 10.1056/NEJMra1400972
   PubMed Web of Science ®Google Scholar
• Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011;11:355. doi: 10.1186/1471-2407-11-355
   PubMed Web of Science ®Google Scholar
• Abboud MR, Ghanem K, Muwakkit S. Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results. Curr Opin Oncol. 2014;26:650–655. doi: 10.1097/CCO.0000000000000125
   PubMed Web of Science ®Google Scholar
• Vecchi V, Pession A, Paolucci G, et al. Risk-directed therapy for childhood acute lymphoblastic leukemia. results of the associazione italiana ematologia oncologia pediatrica ‘82 studies. Cancer. 1993;72:2517–2524. doi: 10.1002/1097-0142(19931015)72:8<2517::AID-CNCR2820720834>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Ceppi F, Cazzaniga G, Colombini A, et al. Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention. Expert Rev Hematol. 2015;8:57–70. doi: 10.1586/17474086.2015.978281
   PubMed Web of Science ®Google Scholar
• Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a children’s oncology group study. Blood. 2008;111:5477–5485. doi: 10.1182/blood-2008-01-132837
   PubMed Web of Science ®Google Scholar
• Eckert C, von Stackelberg A, Seeger K, et al. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia – long-term results of trial ALL-REZ BFM P95/96. Eur J Cancer. 2013;49:1346–1355. doi: 10.1016/j.ejca.2012.11.010
   PubMed Web of Science ®Google Scholar
• Saarinen-Pihkala UM, Parto K, Riikonen P, et al. RALLE pilot: response-guided therapy for marrow relapse in acute lymphoblastic leukemia in children. J Pediatr Hematol Oncol. 2012;34:263–270. doi: 10.1097/MPH.0b013e3182352da9
   PubMed Web of Science ®Google Scholar
• Irving JA. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia. Br J Haematol. 2016;172:655–666. doi: 10.1111/bjh.13852
   PubMed Web of Science ®Google Scholar
• Malempati S, Gaynon PS, Sather H, et al. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children’s Oncology Group study CCG-1952. J Clin Oncol. 2007;25:5800–5807. doi: 10.1200/JCO.2007.10.7508
   PubMed Web of Science ®Google Scholar
• Locatelli F, Schrappe M, Bernardo ME, et al. How I treat relapsed childhood acute lymphoblastic leukemia. Blood. 2012;120:2807–2816. doi: 10.1182/blood-2012-02-265884
   PubMed Web of Science ®Google Scholar
• Jimenez-Hernandez E, Jaimes-Reyes EZ, Arellano-Galindo J, et al. Survival of Mexican children with acute lymphoblastic leukaemia under treatment with the protocol from the Dana-Farber Cancer Institute 00-01. BioMed Res Int. 2015;2015: 576950.
   Web of Science ®Google Scholar
• Mushtaq N, Fadoo Z, Naqvi A. Childhood acute lymphoblastic leukaemia: experience from a single tertiary care facility of Pakistan. J Pak Med Assoc. 2013;63:1399–1404.
   PubMed Web of Science ®Google Scholar
• Campana D. Progress of minimal residual disease studies in childhood acute leukemia. Curr Hematol Malig Rep. 2010;5:169–176. doi: 10.1007/s11899-010-0056-8
   PubMed Web of Science ®Google Scholar
• Sirvent N, Suciu S, Rialland X, et al. Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881. Eur J Cancer. 2011;47:239–247. doi: 10.1016/j.ejca.2010.10.019
   PubMed Web of Science ®Google Scholar
• Barredo JC, Devidas M, Lauer SJ, et al. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. J Clin Oncol. 2006;24:3142–3149. doi: 10.1200/JCO.2005.03.3373
   PubMed Web of Science ®Google Scholar
• Lund B, Åsberg A, Heyman M, et al. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2011;56:551–559. doi: 10.1002/pbc.22719
   PubMed Web of Science ®Google Scholar
• Tallen G, Ratei R, Mann G, et al. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. J Clin Oncol. 2010;28:2339–2347. doi: 10.1200/JCO.2009.25.1983
   PubMed Web of Science ®Google Scholar
• Domenech C, Mercier M, Plouvier E, et al. First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study. Eur J Cancer. 2008;44:2461–2469. doi: 10.1016/j.ejca.2008.08.007
   PubMed Web of Science ®Google Scholar
• Wood AJJ, Pui C-H, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605–615. doi: 10.1056/NEJM199808273390907
   PubMed Web of Science ®Google Scholar
• Jaime-Perez JC, López-Razo ON, García-Arellano G, et al. Results of treating childhood acute lymphoblastic leukemia in a low-middle income country: 10 year experience in northeast Mexico. Arch Med Res. 2016;47:668–676.
   Web of Science ®Google Scholar
• Drachtman RA, Masterson M, Shenkerman A, et al. Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL). Leuk Lymphoma. 2016;57:2275–2280. doi: 10.3109/10428194.2016.1141406
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481. doi: 10.1080/01621459.1958.10501452
   Web of Science ®Google Scholar
• Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A Gen. 1972;135:185–207. doi: 10.2307/2344317
   Web of Science ®Google Scholar
• Cox D. Regression models and life-tables. J R Stat Soc B. 1972;34:187–220.
   Google Scholar
• Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a children’s oncology group study. Leukemia. 2008;22:2142–2150. doi: 10.1038/leu.2008.251
   PubMed Web of Science ®Google Scholar
• Kamps WA, van der Pal-de Bruin KM, Veerman AJP, et al. Long-term results of Dutch childhood oncology group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia. 2010;24:309–319. doi: 10.1038/leu.2009.258
   PubMed Web of Science ®Google Scholar
• Makiya M. Tratamiento de la Leucemia Linfoblástica Aguda Pediátrica Recaída. Hematología. 2013;17:82–88.
   Google Scholar
• Campbell B, Salgado M, Quintana B, et al. Mejoría en el pronóstico de la leucemia linfoblástica aguda en niños de un país en desarrollo: Resultados del protocolo nacional chileno PINDA 87. Rev Chil Pediatr. 1999;70:405–414.
   Google Scholar
• Kuchler H, Buriot D, Maier M, et al. Acute lymphoblastic leukemia in childhood: importance of sex as a prognostic factor (author’s transl). Arch Fr Pediatr. 1982;39:17–21.
   PubMedGoogle Scholar
• Ma H, Sun H, Sun X. Survival improvement by decade of patients aged 0–14 years with acute lymphoblastic leukemia: a SEER analysis. Sci Rep. 2015;4:4227. doi: 10.1038/srep04227
   Web of Science ®Google Scholar
• Orgel E, Genkinger JM, Aggarwal D, et al. Association of body mass index and survival in pediatric leukemia: a meta-analysis. Am J Clin Nutr. 2016;103:808–817. doi: 10.3945/ajcn.115.124586
   PubMed Web of Science ®Google Scholar
• Jaime-Pérez JC, González-Llano O, Herrera-Garza JL, et al. Assessment of nutritional status in children with acute lymphoblastic leukemia in Northern Mexico: a 5-year experience. Pediatr Blood Cancer. 2008;50:506–508. doi: 10.1002/pbc.21397
   PubMed Web of Science ®Google Scholar
• Stary J, Zimmermann M, Campbell M, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol. 2014;32:174–184. doi: 10.1200/JCO.2013.48.6522
   PubMed Web of Science ®Google Scholar
• Matloub Y, Lindemulder S, Gaynon PS, et al. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children’s Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children’s Oncology Group. Blood. 2006;108:1165–1173. doi: 10.1182/blood-2005-12-011809
   PubMed Web of Science ®Google Scholar
• Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse – the Children’s Cancer Group experience. Cancer. 1998;82:1387–1395. doi: 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Borowitz MJ, Wood BL, Devidas M, et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232. Blood. 2015;126:964–971. doi: 10.1182/blood-2015-03-633685
   PubMed Web of Science ®Google Scholar